Working within the uncommon illness area usually means blazing a brand new path — whether or not it’s in drug improvement for an sickness with no accepted medicines or constructing bridges to assist sufferers cross the entry divide.
This yr’s slate of Uncommon Illness Warriors are at the moment dedicating their careers to those lofty pursuits. Whereas some are main medical operations for medication concentrating on unmet wants, others are working to make sure sufferers have entry to therapies that attain the market. And within the close-knit communities of the uncommon illness world, these pharma professionals are sometimes pushed by the deep relationships they forge with sufferers.
Listed below are this yr’s Uncommon Illness Warriors.
Dr. Soraya Bekkali
SVP, head, Europe, Canada and worldwide enterprise, Alexion
Permission granted by Alexion
“From bench to bedside, collaboration is crucial to advancing life-changing therapies.” Learn extra ➔
Dr. Heather Lau
Exec. director, world medical improvement, Ultragenyx Pharmaceutical
Permission granted by Ultragenyx
“You will need to problem prevailing theories and be open to novel approaches.” Learn extra ➔
Carlos Martin
Chief industrial operations, income officer, Rocket Prescription drugs
Permission granted by Rocketl
“We have to guarantee R&D assets go to areas of excessive unmet want — no extra me-too medication.” Learn extra ➔
William Rote
SVP, R&D, Travere Therapeutics
Permission granted by Travere Therapeutics
“Uncommon illness is the place we belong. That is the place we will add essentially the most.” Learn extra ➔
Cheryl Schwartz
SVP, U.S. uncommon illness enterprise unit lead, U.S. industrial operations lead, Takeda
Permission granted by Takeda
“Humility grounds us, reminds us we don’t at all times have the solutions, and encourages us to repeatedly search various views.” Learn extra ➔
